Yimou Biotechnology completes tens of millions of yuan in angel-plus financing.
Summary
Yimou Biotechnology has completed a tens-of-millions-yuan angel-plus financing round. The round was led by BenCao Capital and the Shanghai Future Industry Fund, with participation from several other investors. The company focuses on ophthalmology small-molecule innovative drugs and plans to use the funds to advance clinical trials for its core pipeline YM-101 and continue later-stage development. The financing will also support preclinical validation, process development, clinical filing, and team expansion in clinical, R&D, and quality roles.
Funding
Amount
None
Total raised
Date
June 8, 2026
Announcement date
Investors
-
Lead investors
Company
-
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected